Cool Company Raises · $45.0M · Series A · coherenceneuro.com
Coherence Neuro raises a $45.0M Series A round
Coherence Neuro is a developer of AI-powered oncology medical devices. The company focuses on creating specialized implantable or wearable bioelectronic devices that monitor and treat cancer by analyzing live human biological data. Their efforts aim to advance chronic human clinical trials and seek FDA breakthrough device designation. Coherence Neuro is led by CEO Ben Woodington and CTO Dr. Elise Jenkins.
Visit source
Get the next one by email
One brief each weekday morning. One-click unsubscribe.